Department of Dermatology, Daping Hospital, Third Military Medical University, Chongqing, 400042, China.
Department of Clinical Laboratory Medicine, Daping Hospital, Third Military Medical University, Chongqing, China.
Photodiagnosis Photodyn Ther. 2017 Sep;19:274-277. doi: 10.1016/j.pdpdt.2017.06.015. Epub 2017 Jun 27.
Photodynamic therapy (PDT) has been shown to be a very successful therapy in clinical practice, and its usefulness as a treatment for bacterial infections has been gradually recognized by researchers, who believe it has very good clinical prospects. Atypical mycobacterial skin infections are a type of rare refractory infection. The aim of this study was to evaluate the efficacy and safety of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) combined with antibiotics for the treatment of atypical mycobacterial skin infections.
In this study, 4 patients with atypical mycobacterial skin infections were treated with ALA-PDT combined with antibiotic therapy. These patients were diagnosed with atypical mycobacterial skin infections by bacterial culture and microarray analysis, tests that were also useful for identifying the strains responsible for the infections. In addition to being treated with antibiotics, the skin was also treated locally with ALA-PDT (20% ALA was applied to the lesion and incubated in the dark, then, the lesion was irradiated with a red light with an energy density of 100J/cm) every 10days for a total of 3-5 sessions.
All four patients enrolled in the study were cured with 100% efficiency after receiving combination therapy with ALA-PDT and antibiotics for three months. All patients experienced redness and pain during treatment but did not experience any other forms of severe discomfort and were satisfied with the results of their treatments.
Local ALA-PDT combined with antibiotics is a safe and effective method of treating atypical mycobacterial skin infections.
光动力疗法(PDT)已在临床实践中被证明是一种非常成功的疗法,其作为细菌感染治疗方法的有效性也逐渐被研究人员所认识,他们认为其具有很好的临床前景。非典型分枝杆菌皮肤感染是一种罕见的难治性感染。本研究旨在评估 5-氨基酮戊酸光动力疗法(ALA-PDT)联合抗生素治疗非典型分枝杆菌皮肤感染的疗效和安全性。
本研究采用 ALA-PDT 联合抗生素治疗 4 例非典型分枝杆菌皮肤感染患者。通过细菌培养和微阵列分析对这些患者进行了非典型分枝杆菌皮肤感染的诊断,这些检测也有助于鉴定引起感染的菌株。除了使用抗生素治疗外,还对皮肤进行局部 ALA-PDT 治疗(将 20%的 ALA 涂抹于病变部位,在暗处孵育,然后用能量密度为 100J/cm 的红光照射病变部位),每 10 天进行一次,共进行 3-5 次。
所有纳入研究的 4 例患者在接受 ALA-PDT 联合抗生素治疗三个月后,治愈率达到 100%。所有患者在治疗过程中均出现红肿和疼痛,但未出现其他形式的严重不适,对治疗效果均满意。
局部 ALA-PDT 联合抗生素是治疗非典型分枝杆菌皮肤感染的一种安全有效的方法。